Israeli researchers reported in January that New York, NY-based AposTherapy’s biomechanical shoe-like device, which modulates center of pressure during walking, was associated with improved gait measures and quality of life (QOL) in a yearlong longitudinal study of patients with hip osteoarthritis. Participants underwent gait analysis and reported on QOL measures in questionnaires. They completed the assessments at baseline and after three, six, and 12 months.
Read the original:
Data back AposTherapy device for hip OA